Education
About Us
Working with TipRanks
Follow Us
Long-term Stock Picks - New Portfolio
TJ Lawless
Long-term Stock PicksIndividual Investor
Ranked #421,881 out of 834,043 TipRanks' Investors
Success Rate
189 out of 453
profitable transactions
profitable transactions
Average Return
22.57%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 1.37%
6-Month Return▲ 120.61%
12-Month Return▲ 162.56%
YTD Return▲ 162.51%
Total Return▲ 173.01%
Best Trade
Bio
Biotech companies with great long-term growth prospects
Performance
43.98%0-43.98%
▲ 11.63%
▲ 6.28%
▲ 1.92%
May 2025
▲ 9.25%
▲ 5.14%
▲ 10.82%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 19.46%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 43.98%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 8.67%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 7.93%
Oct 2025
▼ 3.57%
▲ 0.19%
▲ 7.87%
Nov 2025
▲ 1.55%
▲ 1.31%
▲ 1.37%
Dec 2025
▲ 11.63%▲ 6.28%▲ 1.92%
▲ 9.25%▲ 5.14%▲ 10.82%
▲ 7.60%▲ 2.30%▲ 19.46%
▲ 2.76%▲ 2.05%▲ 43.98%
▲ 12.88%▲ 3.56%▲ 8.67%
▲ 10.96%▲ 2.38%▲ 7.93%
▼ 3.57%▲ 0.19%▲ 7.87%
▲ 1.55%▲ 1.31%▲ 1.37%
Recent Activity
Sandstorm Gold
―
▲ 100.63%
2
Close
Oct 17, 2025
Royal Gold
0.52%
▲ 20.42%
1
Open
Oct 17, 2025
Durect
―
▼ 68.48%
2
Close
Sep 11, 2025
DermTech
―
▼ 99.80%
3
Close
Aug 13, 2025
IGM Biosciences
―
▼ 88.73%
2
Close
Aug 13, 2025
Verve Therapeutics
―
▲ 9.91%
4
Close
Jul 24, 2025
Arcus Biosciences
8.61%
▲ 33.64%
3
Buy
Jun 01, 2025
Denali Therapeutics
1.49%
▼ 29.89%
5
Buy
Jun 01, 2025
Ionis Pharmaceuticals
4.22%
▲ 134.33%
1
Open
Jun 01, 2025
Ultragenyx Pharmaceutical
0.52%
▼ 5.40%
1
Open
Jun 01, 2025
Akero Therapeutics
―
▲ 178.13%
4
Close
May 24, 2025
Pfizer
6.59%
▲ 35.13%
5
Open
May 10, 2025
Inmune Bio
1.05%
▼ 81.99%
4
Buy
May 10, 2025
Iovance Biotherapeutics
0.44%
▼ 19.95%
2
Buy
May 10, 2025
AnaptysBio
5.37%
▲ 142.50%
2
Buy
May 10, 2025
Stoke Therapeutics
0.34%
▲ 230.43%
1
Open
May 10, 2025
Altimmune
3.88%
▲ 86.23%
12
Buy
May 07, 2025
Viking Therapeutics
2.88%
▲ 434.63%
7
Buy
May 03, 2025
Ero Copper
2.18%
▲ 91.36%
2
Buy
May 03, 2025
Recursion Pharmaceuticals
0.11%
▼ 26.22%
1
Open
Apr 11, 2025